Promising Results for Chemo-Free Immunotherapy in Early-Stage Triple-Negative Breast Cancer
Phase 2 trial shows potential for immunotherapy without chemo in early TNBC, especially with high TILs.
Study finds vitamin D insufficiency may raise risk of chemotherapy-induced neuropathy in breast cancer.
Phase I/II trial shows adding oleclumab to standard therapy doesn't improve outcomes in advanced TNBC.
Novel drug combination significantly improves progression-free survival in HER2+ metastatic breast cancer
Study finds omega-3 supplements ineffective for preventing pain from paclitaxel chemotherapy in breast cancer
Study finds synbiotic supplements may reduce fatigue, GI issues in breast cancer patients on chemotherapy
9-week trastuzumab regimen nearly matches 1-year in long-term outcomes for early HER2+ breast cancer